Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
18
After four years of research, a new test will help identify cancer in women with ovarian cysts before surgery. Until the OVA1 blood test was created, a precise diagnosis before surgery wasn't possible, said Dr. Frederick R. Ueland, associate professor of gynecologic oncology at the University of Kentucky College of Medicine and a principal investigator on the research project.
16
U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths.
When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information.
12
According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS).
U.S. medical scientists say they've discovered the drug Sprycel, approved for chronic myeloid leukemia, also is effective against ovarian cancer cells.
Results of the FDA pivotal clinical trial for the LightTouch" Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).
Endocyte, Inc., a cancer drug discovery and development company, presented data from a Phase 2a clinical trial for EC145, currently in development as a potential treatment for advanced ovarian cancer.
According to a study from the United States, About half of unaffected BRCA1/2 carriers have a negative family history, confounding efforts toward presymptomatic carrier identification. Ovarian cancer is preventable for known carriers but is otherwise highly lethal.
Several components of the Writ signaling cascade have been shown to function either as tumor suppressor proteins or as oncogenes in multiple human cancers, underscoring the relevance of this pathway in oncogenesis and the need for further investigation of Wnt signaling components as potential targets for cancer therapy.
10
NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the only agent currently approved by the FDA to treat patients with relapsed or refractory peripheral T-cell lymphoma. Investigators from NCCN Member Institutions are eligible to apply for the research funding.
We care about your feedback. Let us know how we can improve your CancerCompass experience.